Citations

Clear

9383 citation(s) found for "Thomas, PS".

Ductal Carcinoma in Situ of the Breast
Hartmann, Lynn C. , Petersen, Ivy A. , Donohue, John H., Crotty, Thomas B., Gisvold, John J., Fonseca, Rafaƫl

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 127 | Issue: 11 | Pages: 1013-1022

10.7326/0003-4819-127-11-199712010-00013 | PMID 9412283 Get It

Smoking and Wrinkles: Does It Matter?
Kottke, Thomas E.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 114 | Issue: 10 | Pages: 908-909

10.7326/0003-4819-114-10-908 | PMID 2014954 Get It

Burnout and Suicidal Ideation among U.S. Medical Students
Thomas, Matthew R. , Massie, F. Stanford, Power, David V. , Eacker, Anne, Harper, William R., Durning, Steven J. , Moutier, Christine , Szydlo, Daniel , Novotny, Paul J. , Sloan, Jeff A. , Dyrbye, Liselotte N. , Shanafelt, Tait D.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 149 | Issue: 5 | Pages: 334-341

10.7326/0003-4819-149-5-200809020-00008 | PMID 18765703 Get It

Viruses in Water
Smith, Thomas F.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 91 | Issue: 1 | Pages: 119-120

10.7326/0003-4819-91-1-119 | PMID 223484 Get It

D-Penicillamine and Lupus Erythematosuslike Syndrome
Harkcom, Thomas M., CONN, DOYT L., HOLLEY, KEITH E., CONN, DOYT L., HOLLEY, KEITH E.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 89 | Issue: 6 | Pages: 1012-1012

10.7326/0003-4819-89-6-1012_1 | PMID 717982 Get It

Bile Acid Breath Test: Extremely Simple, Moderately Useful
Hofmann, Alan F. , Thomas, Paul J.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 79 | Issue: 5 | Pages: 743-744

10.7326/0003-4819-79-5-743 | PMID 4751746 Get It

Unconstrained Shoulder Arthroplasty for Treatment of Proximal Humeral Nonunions
Sperling, John W. , Cofield, Robert H. , Duquin, Thomas R.

Mayo Clinic

JBJS Essential Surgical Techniques | April 10, 2013 | Volume: 3 | Issue: 2 | Pages: e7

10.2106/jbjs.st.m.00001 | PMID 30881738 Get It

Surgical prevention of stroke
Moore, Wesley S. , Brott, Thomas G. , Barleben, Andrew R.

Mayo Clinic

Stroke Management and Recovery | April 10, 2013 | Volume: No volume available | Issue: No issue available | Pages: 100-113

10.2217/ebo.12.460 Get It

Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies
Davies, Paul , Hinkle, Kelly M., Sukar, Nour N., Sepulveda, Bryan, Mesias, Roxana , Alessi, Dario R. , Beach, Thomas G. , Benson, Deanna L. , White, Charles L. , Cowell, Rita M. , Das, Sonal S., West, Andrew B. , Melrose, Heather L. , Serrano, Geidy E. , White, Charles L , Alessi, Dario R

Mayo Clinic

Biochemical Journal | April 9, 2013 | Volume: 453 | Issue: 1 | Pages: 101-113

10.1042/bj20121742 | PMID 23560750 Get It

Missense mutations in LRRK2 (leucine-rich repeat kinase 2) are a major cause of PD (Parkinson's disease). Several antibodies against LRRK2 have been developed, but results using these polyclonal antibodies have varied widely leading to conflicting conclusions. To address this challenge, the Michael J. Fox Foundation for Parkinson's Research generated a number of monoclonal antibodies targeting epitopes across the LRRK2 protein. In the present paper, we report optimized protocols and results for ten monoclonal antibodies for immunoblotting, immunohistochemistry, immunoprecipitation and kinase activity assays, in rat, mouse and human brain tissue. Several efficacious antibodies were identified, but results demonstrate that the mouse monoclonal N241A/34 is suitable for most applications, with the best overall rabbit monoclonal antibody being c41-2. These antibodies produced a dominant band of the expected size via immunoblotting and a lack of labelling in tissue derived from LRRK2-knockout animals under optimized conditions. A significant proportion of LRRK2 protein localizes to insoluble fractions and no evidence of truncated LRRK2 protein was detected in any fraction from rodent or human tissues. An assay was developed for the robust detection of LRRK2 kinase activity directly from frozen mouse and human brain tissue, but precipitous declines in activity were observed that corresponded to increasing post-mortem intervals and processing times. Finally, we demonstrate the highest levels of brain-localized LRRK2 in the striatum, but note differential expression patterns between rat and mouse in both striatum and cortex. Anti-LRRK2 monoclonal antibodies that are unlimited in availability together with the proposed standardized protocols should aid in the definition of LRRK2 function in both health and disease.